Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Debio 4126 |
Synonyms | |
Therapy Description |
Debio 4126 comprises the somatostatin analog octreotide formulated for sustained release, which potentially activates somatostatin receptors leading to decreased angiogenesis and tumor cell proliferation, and increased tumor cell death (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Debio 4126 | Debio-4126|Debio4126 | Debio 4126 comprises the somatostatin analog octreotide formulated for sustained release, which potentially activates somatostatin receptors leading to decreased angiogenesis and tumor cell proliferation, and increased tumor cell death (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|